Venclexta Is a Targeted Cancer Therapy for Blood Cancers

Venclexta (Venetoclax) is a prescription oral medication used to treat certain blood cancers in adults. It belongs to a class of drugs called BCL-2 inhibitors and works by helping cancer cells die through a process called apoptosis — something these cancer cells have learned to avoid. Venclexta is made by AbbVie and Genentech and is taken as a tablet once daily with food.

Unlike traditional chemotherapy, Venclexta is a targeted therapy. It zeroes in on a specific protein that cancer cells depend on, rather than attacking all rapidly dividing cells in your body. This makes it a different kind of treatment with a different side effect profile than what many people associate with cancer therapy.

What Is Venclexta Used For?

Venclexta is FDA-approved for three main conditions:

Chronic Lymphocytic Leukemia (CLL)

CLL is the most common type of leukemia in adults. Venclexta is approved to treat CLL either alone or in combination with other drugs like Obinutuzumab, Rituximab, or Acalabrutinib. It can be used as a first-line treatment or for CLL that has come back after previous treatment.

Small Lymphocytic Lymphoma (SLL)

SLL is closely related to CLL — they're essentially the same disease but differ in where the cancer cells accumulate. Venclexta is approved for SLL with the same combination options as CLL.

Acute Myeloid Leukemia (AML)

Venclexta is approved for newly diagnosed AML in adults who are 75 years or older, or who have health conditions that prevent them from receiving intensive chemotherapy. For AML, Venclexta is used in combination with Azacitidine, Decitabine, or low-dose Cytarabine.

Venclexta is also being studied in clinical trials for other cancers, including mantle cell lymphoma, Waldenström macroglobulinemia, and multiple myeloma.

How Is Venclexta Taken?

Venclexta comes as tablets in three strengths: 10 mg, 50 mg, and 100 mg. There is also a Starter Pack that contains all three tablet strengths for the initial ramp-up period.

Dosing for CLL/SLL

Treatment starts with a 5-week dose ramp-up schedule:

• Week 1: 20 mg once daily
• Week 2: 50 mg once daily
• Week 3: 100 mg once daily
• Week 4: 200 mg once daily
• Week 5 and beyond: 400 mg once daily (the full target dose)

This gradual increase is essential to reduce the risk of a serious complication called tumor lysis syndrome (TLS) — a condition where cancer cells die so rapidly that they overwhelm the kidneys. Learn more about this and other risks in our Venclexta side effects guide.

Dosing for AML

The ramp-up for AML is faster — just 4 days:

• Day 1: 100 mg
• Day 2: 200 mg
• Day 3 and beyond: 400 mg once daily

Important Dosing Rules

• Always take with food — this helps your body absorb the medication properly
• Take at the same time each day
• Swallow tablets whole — do not chew, crush, or break them
• Drink plenty of water — especially during the ramp-up phase (6-8 glasses daily, starting 2 days before your first dose for CLL/SLL)
• If you miss a dose: take it as soon as possible the same day with food. If it's the next day, just take your regular dose — don't double up

Who Should Not Take Venclexta?

Venclexta is not right for everyone. You should not take Venclexta if:

• You are allergic to Venetoclax or any ingredients in the tablet
• You are taking strong CYP3A inhibitors (certain antifungal or antibiotic medications) during the dose ramp-up phase — these drugs can dangerously increase Venclexta levels in your blood

Tell your doctor if:

• You have kidney or liver problems
• You are pregnant, planning to become pregnant, or breastfeeding — Venclexta can harm a developing baby
• You have an electrolyte imbalance
• You take any other medications, supplements, or herbal products — Venclexta has significant drug interactions with many common medications

How Much Does Venclexta Cost?

Venclexta is expensive. Without insurance, expect to pay:

• $15,000–$16,000 per month for the standard 400 mg daily dose (120 tablets of 100 mg)
• ~$3,400 for the Starter Pack (5-week ramp-up supply)
• $131–$139 per tablet (100 mg)

There is no generic version of Venclexta available as of 2026.

Ways to Save

Despite the high cost, many patients pay significantly less — and some pay nothing out of pocket:

• Genentech Co-pay Assistance Program — Eligible commercially insured patients may pay $0. Call 855-692-6729 or visit copayassistancenow.com.
• Genentech Patient Foundation — Free medication for eligible uninsured patients.
• VENCLEXTA Access Solutions — Comprehensive support for insurance navigation, co-pay assistance, and free drug programs.
• HealthWell Foundation — Additional co-pay support for qualifying patients.

For a complete guide to financial assistance, read How to Save Money on Venclexta.

Insurance Coverage

Most commercial insurance plans and Medicare cover Venclexta, but it typically requires prior authorization. It's usually placed on the specialty or highest formulary tier. Your oncologist's office will handle the prior authorization process, but it can take several days to a few weeks.

Final Thoughts

Venclexta represents a major advance in how we treat blood cancers like CLL, SLL, and AML. It's a targeted therapy that offers an alternative to traditional chemotherapy, with a different — and for many patients, more manageable — side effect profile.

The keys to successful Venclexta treatment are: following the dose ramp-up schedule carefully, staying hydrated, keeping your monitoring appointments, and being aware of drug interactions and warning signs.

If you're looking for a specialist who prescribes Venclexta, visit Medfinder to find providers near you. And learn more about how Venclexta works at the molecular level or how to find it at a pharmacy.